Knowledgebase

Electromagnetic hypersensitivity

EMR Australia - Friday, January 29, 2016

Recent studies shed new insights on the condition of electromagnetic hypersensitivity (EHS).

Diagnosis and treatment

A group of 17 scientists from six nations has produced the EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses’. 1

Their paper reports the results of Professor Belpomme’s study on 1200 people with EHS and/or multiple chemical sensitivity (MCS). ‘Both EHS and MCS appear to paint a common picture of inflammation-related hyper-histaminemia, oxidative stress, autoimmune response and BBB [blood-brain-barrier] opening, and a deficit in melatonin excretion.’

As a first step, the authors recommend that sufferers measure fields at home and work and take action to reduce their exposure.

The authors also recommend a number of diagnostic tests as well as treatments, including oxidation, treating intestinal problems, improving nutrition, detoxification, improving mitochondrial function, reducing inflammation, sauna, exposure to natural light, oxygen therapy, exercise, drinking good quality water and appropriate dental care.

EHS perspective

The Swedish government classifies EHS as a ‘functional impairment’ - that is, a difficulty that limits the sufferer’s ability to engage in certain essential activities of life.2 This means that sufferers are not ‘seen as patients but citizens reacting to an inferior environment,’ said author, Professor Olle Johansson of Karolinska Institute. As a result of this approach, sufferers are not subjected to a battery of diagnostic tests and are not prescribed psychiatric treatments—as is recommended in many countries, including Australia.

The Swedish approach to EHS also enables sufferers to obtain economic support and legal protection.

In his paper, Professor Johansson describes the results of his research which showed that EHS people exposed to electromagnetic radiation had skin damage consistent with other forms of radiation exposure. Specifically, he found changes in the numbers and behaviours of mast cells, which are involved in pain, itching, edema and erythema— symptoms that are reported by many EHS sufferers.

EHS is not a nocebo effect

No, electromagnetic hypersensitivity is not a psychological (nocebo) effect, says M Dieudonné from France. After interviewing 40 people claiming to have EHS, Dr Dieudonné determined that symptoms appeared before people began questioning the effects of electromagnetic fields on their health—and not as a result of their negative perceptions about technology.

1. Belyaev, I et al, ‘EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses,’ Rev Environ Health, 30 (4):337-71, 2015.

2. Johansson, O, ‘Electrohypersensitivity: a functional impairment due to an inaccessible environment’, Rev Environ Health, 30(4):311-21, 2015.

3. Dieudonné, M, ‘Does electromagnetic hypersensitivity originate from nocebo responses? Indications from a qualitative study’, Bioelectromagnetics 37(1), 14-24,


About The Author - Lyn McLean is a consumer advocate, author and educator and has been monitoring and writing on the subject of electromagnetic radiation (EMR) for over 20 years. She is the director of EMR Australia.


Follow on Feedly follow us in feedly


Trackback Link
http://www.emraustralia.com.au/BlogRetrieve.aspx?BlogID=419&PostID=620973&A=Trackback
Trackbacks
Post has no trackbacks.

Recent Posts

Categories

Tags

Dr Cornelia Waldmann-Selsam ARPANSA RF Standard Professor Bruce Armstrong Frank Drews Dr Kenneth Foster Dr. Henry Lai Dr Lennart Hardell Dr Ronald Powell Kaspersky Lab Vijayalaxmi and Maria Scarfi US Senate Hearing Frank Clegg Dr Martin Pall John Cherry Dr Dieudonné Dr Don Masich Dr Jacquinta Lee Dr. Masayuki Tatemichi Prof Andrew Marino Dr Stephanie McCarter (MD) Professor Michael Berk Dr Linda Erdreich Dr Olga Naidenko Dr Magda Havas Catalyst Dr Hugh Taylor Dr Lawrence Anukam Ohio State University Dr Larry Marshall Dr James Oschman Professor Hugo Lagercrantz SCENIHR Report Dr. Neil Cherry Dr Maryanne Demasi Professor Belpomme Lennart Hardell Professor Anthony Miller Dr Mary Redmayne Dr Louis Slesin Alasdair Phillips Dr William Rea Dr Dominique Belpomme Dr Priyanka Bandara Dr Devra Davis Ken Karipidis David Suzuki Michael Dolan Dr Igor Belyaev Dr Christine Aschermann Prof Olle Johansson IAFF Mr Gary Melik Dr David Carpenter Paul Wentworth Venice Resolution Essex University Study Professor Martin Pall Dr Dariuz Leszczynski Dr Cyril Smith Michael Carlberg Grant Brecht Dr Lisa Nagy Professor Rodney Croft John Patterson Dr Christopher Portier Dr Markus Kern Sydney Council Phone Tower Forum Mona Nilsson A. Garcia Dr Asad Rahmani Dr John Dockerty Dr James Suckling Cindy Sage Dr Michael Kundi Dr Ron Overberg Anne Silk Dennis J Kucinich Dr, Louis, Slesin Specific Absorption Rate (SARs) SAM Model WHO Dr Stephen Solomon Dr Siegal Sadetzki Dr Fernando Saravi Dr Gilbert de Paula (MD) Dr De-Kun Li Prof Trevor Marshall Dr Arpad Szallasi (MD) Associate Professor Ray Kearney OAM Dr S Mortazavi T Abelin Stewart Committee Reports E Lopez-Martin Dr Jean Monroe Brett Moule Jim Phillips Salzburg Resolution

Archive

SuMoTuWeThFrSa
  12345
6789101112
13141516171819
20212223242526
2728293031  

EMR Australia © 2017. All Rights Reserved. Terms & Conditions | Privacy | Sitemap | Adobe Business Catalyst Sydney